A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH. Worth a look for patients with FST V–VI
Facial rejuvenation that’s both effective and safe in darker skin tones remains a challenge, and this Antioxidant Biostimulating Treatment (ABT) aims squarely at that gap. By using a multi‑acid system to create controlled epidermal fissures, ABT ferries phytocompound antioxidant acids into the dermis to stimulate renewal while minimizing inflammation.
In patients with Fitzpatrick V-VI and mild-moderate concerns, three sessions spaced four weeks apart produced measurable gains in overall appearance, radiance, and skin smoothness with no reported postinflammatory hyperpigmentation or other adverse events. The concept blends peel mechanics with biostimulatory goals but claims a better safety profile in higher phototypes. For clinicians, the intriguing parts are the delivery method, tolerated dosing, and the apparent absence of PIH – all critical when treating darker skin.
Want to learn more? Read the full paper – it’s concise and immediately relevant to clinic practice.
J Drugs Dermatol. 2025;24(10) doi:10.36849/JDD.9002
Blog write-up assisted by AI
